426 related articles for article (PubMed ID: 36555339)
1. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
3. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
4. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
Front Immunol; 2023; 14():961642. PubMed ID: 37026010
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.
Yoon H; Dean LS; Jiyarom B; Khadka VS; Deng Y; Nerurkar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
Front Immunol; 2023; 14():1268510. PubMed ID: 38259488
[TBL] [Abstract][Full Text] [Related]
6. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
Zheng Q; Wang D; Lin R; Lv Q; Wang W
Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
Ting CT; Chen BS
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
Front Immunol; 2022; 13():918692. PubMed ID: 36059456
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease.
Zhang C; Ma Z; Nan X; Wang W; Zeng X; Chen J; Cai Z; Wang J
Front Immunol; 2023; 14():1024041. PubMed ID: 36817436
[TBL] [Abstract][Full Text] [Related]
10. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
Xie TA; He ZJ; Liang C; Dong HN; Zhou J; Fan SJ; Guo XG
Eur J Med Res; 2021 Dec; 26(1):146. PubMed ID: 34920753
[TBL] [Abstract][Full Text] [Related]
11. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV.
Yan C; Niu Y; Wang X
Front Immunol; 2022; 13():1008653. PubMed ID: 36389792
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics and system biology approach to identify the influences among COVID-19, ARDS and sepsis.
Li P; Li T; Zhang Z; Dai X; Zeng B; Li Z; Li Z
Front Immunol; 2023; 14():1152186. PubMed ID: 37261353
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Approaches to Identify the Comorbidity Complexities of SARS-CoV-2 Infection with Crohn's Disease.
Li Y; Han X
J Coll Physicians Surg Pak; 2023 Oct; 33(10):1093-1099. PubMed ID: 37804012
[TBL] [Abstract][Full Text] [Related]
14. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
Taz TA; Ahmed K; Paul BK; Kawsar M; Aktar N; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1254-1266. PubMed ID: 33024988
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).
Tian Z; Cen L
Pol J Microbiol; 2023 Jun; 72(2):143-154. PubMed ID: 37216361
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection.
García-Hidalgo MC; Peláez R; González J; Santisteve S; Benítez ID; Molinero M; Perez-Pons M; Belmonte T; Torres G; Moncusí-Moix A; Gort-Paniello C; Aguilà M; Seck F; Carmona P; Caballero J; Barberà C; Ceccato A; Fernández-Barat L; Ferrer R; Garcia-Gasulla D; Lorente-Balanza JÁ; Menéndez R; Motos A; Peñuelas O; Riera J; Bermejo-Martin JF; Torres A; Barbé F; de Gonzalo-Calvo D; Larráyoz IM
Biomed Pharmacother; 2022 Oct; 154():113617. PubMed ID: 36058144
[TBL] [Abstract][Full Text] [Related]
17. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
Venkataraman T; Coleman CM; Frieman MB
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
[TBL] [Abstract][Full Text] [Related]
18. Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS.
García-Hidalgo MC; González J; Benítez ID; Carmona P; Santisteve S; Pérez-Pons M; Moncusí-Moix A; Gort-Paniello C; Rodríguez-Jara F; Molinero M; Belmonte T; Torres G; Labarca G; Nova-Lamperti E; Caballero J; Bermejo-Martin JF; Ceccato A; Fernández-Barat L; Ferrer R; Garcia-Gasulla D; Menéndez R; Motos A; Peñuelas O; Riera J; Torres A; Barbé F; de Gonzalo-Calvo D;
Emerg Microbes Infect; 2022 Dec; 11(1):1537-1549. PubMed ID: 35603455
[TBL] [Abstract][Full Text] [Related]
19. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets.
O'Reilly S
QJM; 2023 Oct; 116(9):750-754. PubMed ID: 37191984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
